Canadian Researchers Identify New Glioblastoma Treatment Pathway Using Existing HIV Drug
A team of researchers in Canada has discovered a new method to slow the growth of glioblastoma, a highly aggressive and currently incurable brain cancer. The study, conducted by scientists at McMaster University and The Hospital for Sick Children (SickKids), reveals that certain brain cells, previously thought to only support normal nerve function, can actually aid in the growth and spread of glioblastoma. These cells communicate with tumor cells, strengthening them. By blocking this communication in laboratory models, researchers observed a significant reduction in tumor growth. The study also highlights a potential treatment opportunity using an existing HIV drug, Maraviroc, which could interfere with this process. This discovery offers a new treatment option for patients who currently have limited choices, as glioblastoma often results in survival measured in months. 
